NovoSkin was developed by the Sheneskin biotech company, based in the industrial center of Buryatia, to treat burns, hard-to-heal wounds, and ulcers.

The agency stated that the wound dressing to human skin, consisting of a collagen-laminin matrix, will be available in all Russian medical institutions.”

jg/iff/jha/gfa